Ernexa Therapeutics: makes investor presentation available

What happened Ernexa Therapeutics, a Delaware corporation, announced on Oct 15, 2026 that it made available a presentation for investors. The filing states a copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by reference.

Key details

• Filing date: Oct 15, 2026.
• Item reported: Item 7.01, Regulation FD disclosure.
• Exhibit attached: Exhibit 99.1, "Ernexa Therapeutics Investor Presentation - October 2026".

Why it may matter This report covers Item 7.01 (Regulation FD disclosure), which relates to disclosure made available to investors. The filing does not show why the insider traded or why the company acted.